保健品中一种新型他达拉非相关化合物的结构鉴定

    Structure Identification of a New Tadalafil Related Compound in Dietary Supplement

    • 摘要: 目的 鉴定保健品中发现的一种新型他达拉非化合物的结构。方法 通过高效液相色谱-二极管阵列检测器联用筛查,发现一种补肾壮阳类保健食品中添加了一种他达拉非类化合物。经过制备液相提纯后,得到目标化合物,用高效液相色谱-四级杆/飞行时间质谱获得相对分子质量和结构碎片。结合核磁共振氢谱和碳谱及相关文献数据,鉴定出该化合物的结构。结果 在保健品中发现添加了一种新型的他达拉非类化合物二乙氨基前他达拉非。结论 该化合物不在现有补肾壮阳类中成药检验标准的11种目标化合物范围内,有必要加以研究。

       

      Abstract: OBJECTIVE To identify a new tadalafil related compound adulterated in a dietary supplement. METHODS A new tadalafil related compound was detected in a routine screening for compounds adulterated in a dietary supplement by HPLC-DAD. The target compound was isolated by preparative high performance liquid chromotography. Its molecular weight and structural fragments were obtained by HPLC-MS/MS. 1H-NMR spectrum and 13C-NMR spectrum were obtained by means of nuclear magnetic resonance. Its structure was identified by analysis of all these data and related textual comparison. RESULTS A new tadalafil related compound named diethylaminopretadalafil was detected in a dietary supplement. CONCLUSION The compound is not in the current inspection standard lists, which includes 11 target compounds. It is necessary to study this compound.

       

    /

    返回文章
    返回